Page 70 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer
P. 70

Table 3. Eligibility criteria for enrollment in protocols with curative intent in chronological order of starting enrollment year
 Center,   Term used  Age   Gleason   # biopsy   PSA   Imaging   Stage   Behavioral indication (other than patients’
 Country   in original   (yr)   score   cores /%   (ng/mL)   choice or preference)
 [Pubmed ID]   article   cores

 Enrollment
 years
 Baylor College   EM   –   <7   TRUS   –   –   –   Decision for deferred therapy was made by the
 of Medicine and   /deferred   guided   patient and treating physician together based on
 MSKCC, US 106    therapy   sextant   the likely presence of small volume cancer.
 [15017211]   biopsy

 1984-2001
 McGill Univ.,   WW; AS   –   –   TRUS   –   –   “Clinically   Limited life expectancy because of advanced
 Canada 107    guided   localized   age or poor medical condition
                      26
 [18484590]   biopsy   caner” )

 1987-2002
 Univ. of   AS   –   –   –   –   –   “low-risk   Patients who elected WW or AS program. Men
 Connecticut   disease”           on WW were generally older with localized
 Health Center,                   prostate cancer who did not desire aggressive
 US 108                           intervention. Men on AS were generally younger
 [18707696]                       with low-risk disease.

 1990-2006
 Four tertiary   AS   ≤75   ≤6   ≤3 positive   ≤10   MRI of the   T1-T2a   –
 care academic   cores at   prostate was
 medical   diagnostic   selectively
 a
 canters,  US 109    biopsy   used at
 [19233410]    diagnosis

 1991-2007
 Univ. of Miami,   AS; WW 123    ≤80 122   ≤6 110    TRUS guided   ≤15 110    –   ≤T2/T2b 110    MD influence had the greatest
 US 110,122,123    biopsy                         impact on choosing AS (73%),
 [17850361;      ≤10 122,123                      concerns for incontinence (48%)
 20800964;   ≤50% of 2                            and erectile dysfunction (44%)
 21215429]   biopsy cores 110                     also reasons for choosing AS  122

 1991-2007   ≤2 biopsy cores
 with ≤20% in
 each core 123










 34
   65   66   67   68   69   70   71   72   73   74   75